AMAG Pharmaceuticals Inc

Entity type image
Type: Company
Name: AMAG Pharmaceuticals Inc
First reported May 16 2013 - Updated May 16 2013 - 1 reports

AMAG Pharmaceuticals (AMAG) Trading Near $24.86 Support Level

AMAG Pharmaceuticals (NASDAQ: AMAG) closed Wednesday's trading session at $25.43. In the past year, the stock has hit a 52-week low of $12.43 and 52-week high of $25.67. AMAG Pharmaceuticals (AMAG) stock has been showing support around $24.86 and resistance ... [Published MarketIntelligenceCenter.com - May 16 2013]
First reported May 15 2013 - Updated May 15 2013 - 1 reports

AMAG Pharmaceuticals Looks to Continue...

AMAG Pharmaceuticals (NASDAQ:AMAG) traded today at a new 52-week high of $25.58. Approximately 75,000 shares have changed hands today, as compared to an average 30-day volume of 153,000 shares. AMAG Pharmaceuticals (NASDAQ:AMAG) is currently priced 33.5% ... [Published Financial News Network online - May 15 2013]
First reported May 10 2013 - Updated May 10 2013 - 1 reports
H&E Equipment Services Inc
H&E Equipment Services Inc

AMP, KIE, AMAG, SDY, LORL, HEES Are Seasonally Ripe To Go Down In the Next Five Weeks

BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of AMERIPRISE FINANCIAL, INC. (NYSE:AMP), Kbw Insurance Etf (NYSE:KIE), AMAG Pharmaceuticals Inc (NASDAQ:AMAG), SPDR S&P Dividend ETF (NYSE:SDY), Loral Space and Communications Inc (NASDAQ:LORL), ... [Published Individual.com - May 10 2013]
First reported May 08 2013 - Updated May 08 2013 - 1 reports

Watch for Continued Gains in Shares of AMAG Pharmaceuticals (AMAG)

(Financial News NetwFork O) Shares of AMAG Pharmaceuticals (NASDAQ:AMAG) traded today at $24.56, breaking its 52-week high. So far today approximately 64,000 shares have been exchanged, as compared to an average 30-day volume of 156,000 shares. In the ... [Published Individual.com - May 08 2013]
First reported May 03 2013 - Updated May 03 2013 - 1 reports

Buyers Accumulate Shares of AMAG Pharmaceuticals, Up 3.8%

(Financial News Network On) One of today's notable stocks on the rise is AMAG Pharmaceuticals (NASDAQ:AMAG), up 3.8% to $22.95. The Dow Jones Industrial Average is now trading 1.2% higher to 15,004 and the S&P is trading 1.3% higher to 1,618. AMAG. ... [Published Individual.com - May 03 2013]
First reported May 03 2013 - Updated May 03 2013 - 1 reports

Potential AMAG Pharmaceuticals (AMAG) Trade Targets 21.53% Return

AMAG Pharmaceuticals (NASDAQ: AMAG) closed Thursday's trading session at $22.11. In the past year, the stock has hit a 52-week low of $12.43 and 52-week high of $23.98. AMAG Pharmaceuticals (AMAG) stock has been showing support around $21.55 and resistance ... [Published MarketIntelligenceCenter.com - May 03 2013]
First reported May 02 2013 - Updated May 02 2013 - 1 reports

AMAG reports lower Q1 net loss, provides outlook for 2013

AMAG Pharmaceuticals, Inc., a biopharmaceutical company, has reported that net loss for the first quarter ended March 31, 2013 was $3.89 million, or $0.18 loss per share, compared to a net loss of $12.42 million, or $0.58 loss per share, for the same ... [Published Individual.com - May 02 2013]
First reported Apr 29 2013 - Updated Apr 29 2013 - 2 reports

AMAG Pharmaceuticals (AMAG) Could Fall Through $21.40 Support Level

AMAG Pharmaceuticals (NASDAQ: AMAG) closed Friday's trading session at $21.89. In the past year, the stock has hit a 52-week low of $12.43 and 52-week high of $23.98. AMAG Pharmaceuticals (AMAG) stock has been showing support around $21.40 and resistance ... [Published Scottrade - Apr 29 2013]
First reported Apr 26 2013 - Updated Apr 26 2013 - 1 reports

AMAG Pharmaceuticals to Present at the Needham Healthcare Conference

LEXINGTON, Mass.--(BUSINESS WIREA live webcast of the presentation will be accessible through the Investors section of the company’s website at$ www.amagpharma.com. Following the conference, the webcast will be archived on the$ AMAG Pharmaceuticals, Inc.$ ... [Published EON - Apr 26 2013]
First reported Apr 24 2013 - Updated Apr 24 2013 - 1 reports

AMAG Pharmaceuticals, Inc. Announces First Quarter 2013 Financial Results

AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG), a specialty pharmaceutical company, today reported unaudited consolidated financial results for the quarter ended March 31, 2013. Total revenues for the first quarter of 2013 were $17.9 million, 16 percent greater ... [Published BioSpace - Apr 24 2013]
First reported Apr 24 2013 - Updated Apr 24 2013 - 1 reports

AMAG Pharmaceuticals' CEO Discusses Q1 2013 (Results - Earnings Call Transcript

AMAG Pharmaceuticals ( AMAG ) Q1 2013 Earnings Call April 23, 2013 16:30 pm ET Executives Amy Sullivan - VP, Investor Relations Bill Heiden, - President and CEO Frank Thomas - COO Greg Madison - CCO Analysts Joe Schwartz - Leerink Swann ... [Published Healthcare Sector and Stocks Analysis from Seek ... - Apr 24 2013]
First reported Apr 23 2013 - Updated Apr 23 2013 - 1 reports

AMAG Pharmaceuticals (AMAG) Trading Near $20.43 Support Level

AMAG Pharmaceuticals (NASDAQ: AMAG) closed Monday's trading session at $20.98. In the past year, the stock has hit a 52-week low of $12.43 and 52-week high of $23.98. AMAG Pharmaceuticals (AMAG) stock has been showing support around $20.43 and resistance ... [Published MarketIntelligenceCenter.com - Apr 23 2013]

Quotes

...Melvin H Seid, Director of Clinical Research at Lyndhurst Gynecologic Associates in Winston Salem, N C and a Principal Investigator for the trial. "Participants in this trial who were treated with ferumoxytol had significant increases in hemoglobin, which directly correlated to improvements in self-reported measures of fatigue. AUB patients with iron deficiency anemia who have not responded well to oral iron supplementation have a need for additional treatment options. The analysis from this study supports the potential of ferumoxytol as a new treatment option for patients with IDA from AUB who have previously had an unsatisfactory response to oral iron therapy."
AMAG announces encouraging data from Phase III iron deficiency anemia study [Published Individual.com - May 17 2013]
"We started moving to Google Docs in 2009. We still had our [Documentum] eRoom server in for stuff we considered sensitive. We were waiting for someone to give us a product that gives us audit level control over Google Docs" says McBride, who is speaking at the CITE Conference next month
The critical catalyst that let this drug company go 100% cloud [Published CITEWorld - May 13 2013]
...By tracking the size and price of each montha'a "s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin."
AMP, KIE, AMAG, SDY, LORL, HEES Are Seasonally Ripe To Go Down In the Next Five Weeks [Published Individual.com - May 10 2013]
...One of the things he told me one day, after I'd come into his office with some frustration about a particular functional line, was, "You know, if you don't piss off 20% of the people that you meet every day, you're not doing our job." I've always remembered that one
Best career advice for IT executives looking to excel in their field [Published CIO Decisions - May 07 2013]

More Content

All (107) | News (46) | Reports (2) | Blogs (22) | Audio/Video (0) | Fact Sheets (0) | Press Releases (37)
sort by: Date | Relevance
AMAG Pharma Says Ferumoxytol Treatment Produced... [Published Benzinga.com - 3 hours ago]
Ferumoxytol Treatment Produced Significant Hemo... [Published GlobeNewswire: Acquisitions News - 4 hours ago]
AMAG Pharmaceuticals, Inc. (AMAG) - Pharmaceuti... [Published Live-PR.com - 6 hours ago]
AMAG announces encouraging data from Phase III ... [Published Individual.com - May 17 2013]
AMAG Pharmaceuticals (AMAG) Trading Near $24.86... [Published MarketIntelligenceCenter.com - May 16 2013]
AMAG Pharmaceuticals Looks to Continue... [Published Financial News Network online - May 15 2013]
Shares of AMAG Pharmaceuticals Rise Above Previ... [Published Individual.com - May 13 2013]
The critical catalyst that let this drug compan... [Published CITEWorld - May 13 2013]
AMAG Pharmaceuticals (AMAG) Showing Bullish Tec... [Published MarketIntelligenceCenter.com - May 10 2013]
AMP, KIE, AMAG, SDY, LORL, HEES Are Seasonally ... [Published Individual.com - May 10 2013]
Watch for Continued Gains in Shares of AMAG Pha... [Published Individual.com - May 08 2013]
Iron Deficiency Anemia Pipeline Reviewed by Glo... [Published Business Wire - May 07 2013]
Best career advice for IT executives looking to... [Published CIO Decisions - May 07 2013]
Ferumoxytol Results in Significant Hemoglobin I... [Published GlobeNewswire: Acquisitions News - May 06 2013]
Buyers Accumulate Shares of AMAG Pharmaceutical... [Published Individual.com - May 03 2013]
Potential AMAG Pharmaceuticals (AMAG) Trade Tar... [Published MarketIntelligenceCenter.com - May 03 2013]
IDG Enterprise's CITE Conference + Expo Release... [Published Individual.com - May 03 2013]
AMAG reports lower Q1 net loss, provides outloo... [Published Individual.com - May 02 2013]
Special report: Contrast injectors and agents [Published Dotmed - Apr 30 2013]
Groundbreaking Consumerization of IT Conference... [Published Scottrade - Apr 30 2013]
AMAG Pharmaceuticals (AMAG) Could Fall Through ... [Published Scottrade - Apr 29 2013]
AMAG Pharmaceuticals (AMAG) Could Fall Through ... [Published MarketIntelligenceCenter.com - Apr 29 2013]
Amag Releases 1Q 2013 Unaudited Results [Published Individual.com - Apr 29 2013]
AMAG Pharmaceuticals to Present at the Needham ... [Published EON - Apr 26 2013]
AMAG Pharmaceuticals to Present at the Needham ... [Published Business Wire - Apr 26 2013]
AMAG Pharmaceuticals to Present at the Needham ... [Published EON Business - Apr 26 2013]
AMAG Pharmaceuticals to Present at the Needham ... [Published Business Wire Health News - Apr 26 2013]
AMAG Narrows Loss; Maintains View Zacks [Published Yahoo! Finance - Apr 24 2013]
AMAG Pharmaceuticals, Inc. Announces First Quar... [Published BioSpace - Apr 24 2013]
AMAG Pharmaceuticals' CEO Discusses Q1 2013 (Re... [Published Healthcare Sector and Stocks Analysis from Seek ... - Apr 24 2013]
1 2 3 4
In Focus
  •  
Amy Sullivan, Frank Thomas, Lee F Allen, [more]
  •  
Leerink Swann & Co Inc, JPMorgan Chase & Co, Takeda Pharmaceutical Co Ltd, [more]
  •  
FDA Food & Drug Administration, American Society of Hematology, European Medicines Agency, [more]
  •  
Healthcare Conference, Ferumoxytol, 8-k, [more]
  •  
Feraheme, Xignite Financials, Boeing 787, [more]
  •  
Madison (Wisconsin, United States), Boston (Massachusetts, United States), San Francisco (United States), [more]
  •  
United States, Kenya, Japan, [more]
  •  
Diseases, Medication, Research & Development, [more]
  •  
Aerospace & Defense, IT, Telecom, [more]
MarketIntelligenceCenter.com, EON Business, Business Wire Health News, [more]
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
AMAG Pharmaceuticals (AMAG) Trading Near $24.86... [Published MarketIntelligenceCenter.com - May 16 2013]
AMAG Pharmaceuticals (NASDAQ: AMAG) closed Wednesday's trading session at $25.43. In the past year, the stock has hit a 52-week low of $12.43 and 52-week high of $25.67. AMAG Pharmaceuticals (AMAG) stock has been showing support around $24.86 and resistance ...
AMAG Pharmaceuticals (AMAG) Showing Bullish Tec... [Published MarketIntelligenceCenter.com - May 10 2013]
AMAG Pharmaceuticals (NASDAQ: AMAG) closed Thursday's trading session at $23.45. In the past year, the stock has hit a 52-week low of $12.43 and 52-week high of $24.56. AMAG Pharmaceuticals (AMAG) stock has been showing support around $23.18 and resistance ...
Potential AMAG Pharmaceuticals (AMAG) Trade Tar... [Published MarketIntelligenceCenter.com - May 03 2013]
AMAG Pharmaceuticals (NASDAQ: AMAG) closed Thursday's trading session at $22.11. In the past year, the stock has hit a 52-week low of $12.43 and 52-week high of $23.98. AMAG Pharmaceuticals (AMAG) stock has been showing support around $21.55 and resistance ...
AMAG Pharmaceuticals (AMAG) Could Fall Through ... [Published MarketIntelligenceCenter.com - Apr 29 2013]
AMAG Pharmaceuticals (NASDAQ: AMAG) closed Friday's trading session at $21.89. In the past year, the stock has hit a 52-week low of $12.43 and 52-week high of $23.98. AMAG Pharmaceuticals (AMAG) stock has been showing support around $21.40 and resistance ...
AMAG Pharmaceuticals (AMAG) Trading Near $20.43... [Published MarketIntelligenceCenter.com - Apr 23 2013]
AMAG Pharmaceuticals (NASDAQ: AMAG) closed Monday's trading session at $20.98. In the past year, the stock has hit a 52-week low of $12.43 and 52-week high of $23.98. AMAG Pharmaceuticals (AMAG) stock has been showing support around $20.43 and resistance ...
1 2 3 4 5

Press Releases

sort by: Date | Relevance
Ferumoxytol Treatment Produced Significant Hemo... [Published GlobeNewswire: Acquisitions News - 4 hours ago]
Iron Deficiency Anemia Pipeline Reviewed by Glo... [Published Business Wire - May 07 2013]
Ferumoxytol Results in Significant Hemoglobin I... [Published GlobeNewswire: Acquisitions News - May 06 2013]
AMAG Pharmaceuticals to Present at the Needham ... [Published Business Wire - Apr 26 2013]
AMAG Pharmaceuticals to Present at the Needham ... [Published EON Business - Apr 26 2013]
1 2 3 4 5 6 7 8
About
Silobreaker
Press Room
Products
Online Service
On-Premises Software
Contact Us
Sales
Support
Legal
Terms of Use
Privacy Policy


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2013 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.